OpenFlux
Retour aux articles
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
IA Programmation Web

Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

TechCrunch ·

The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

Lire l'article original

Articles similaires